Lower solvency than 95% of companies in human health. The sector median is 63.0%, over 21,385 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 3,634 companies had the same profile as GYNECOLOGY SOCIETY DEVELOPMENT has now. Each dot stands for 10 companies, two years later.
91.9%
were still trading
4.8%
stopped another way
3.2%
went bankrupt
Micro
10 to 20 years old
negative equity
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,634 companies, not a prediction for GYNECOLOGY SOCIETY DEVELOPMENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered office moved from Boussire to Waimes
The registered office moved from Rue des Hêtres 5 à 4960 Boussire to Route de Hottleux 112/1 4950 Waimes · Board meeting of 23-09-2025 · Gazette deed
Registered office moved from Waimes to Montigny-le-Tilleul
The registered office moved from Route de Hottleux 112/1 à 4950 Waimes to Rue de la Croix Rouge 36 6110 Montigny-le-Tilleul · Board meeting of 28-09-2023 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as GYNECOLOGY SOCIETY DEVELOPMENT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €32,600 and €63,800, founded between 2006 and 2014.
What is the company number of GYNECOLOGY SOCIETY DEVELOPMENT?
The company number of GYNECOLOGY SOCIETY DEVELOPMENT is 0807.537.767. The VAT number is the same number with BE in front: BE 0807.537.767.
Where is GYNECOLOGY SOCIETY DEVELOPMENT based?
The registered office is at Boussire - Rue des Hêtres 5, 4960 Malmedy.Company details
What does GYNECOLOGY SOCIETY DEVELOPMENT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GYNECOLOGY SOCIETY DEVELOPMENT?
GYNECOLOGY SOCIETY DEVELOPMENT is a private limited company (pre-2019) (BVBA).
When was GYNECOLOGY SOCIETY DEVELOPMENT founded?
GYNECOLOGY SOCIETY DEVELOPMENT was founded on 03-11-2008.
Is GYNECOLOGY SOCIETY DEVELOPMENT still active?
Yes, GYNECOLOGY SOCIETY DEVELOPMENT is an active enterprise in the KBO register.
How many employees does GYNECOLOGY SOCIETY DEVELOPMENT have?
GYNECOLOGY SOCIETY DEVELOPMENT had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of GYNECOLOGY SOCIETY DEVELOPMENT?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €34,411 and 47 comparable companies (NACE 86). It probably lies between €76,000 and €150,000.
Is GYNECOLOGY SOCIETY DEVELOPMENT profitable?
In financial year 2025, GYNECOLOGY SOCIETY DEVELOPMENT made a profit of €3,111.
Where can I find the annual accounts of GYNECOLOGY SOCIETY DEVELOPMENT?
GYNECOLOGY SOCIETY DEVELOPMENT filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GYNECOLOGY SOCIETY DEVELOPMENT due?
GYNECOLOGY SOCIETY DEVELOPMENT must file the annual accounts for financial year 2026 by 31-05-2027.Timeline